Your session is about to expire
← Back to Search
Lefamulin for Mycoplasma Genitalium Infection
Study Summary
This trial will test whether the antibiotic Xenleta can cure Mycoplasma genitalium infections when other antibiotics have failed, and whether taking doxycycline first makes it more effective.
- Mycoplasma Genitalium Infection
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What medical maladies does Lefamulin commonly address?
"Patients with severe acne, disease, or even trachoma may find relief through the administration of Lefamulin."
Are individuals being onboarded into this trial at the present?
"Affirmative. According to the records found on clinicaltrials.gov, this trial has been open for recruitment since April 22nd 2022 and is still actively searching for 40 participants from one medical site."
What is the cap on total participants in this research experiment?
"Affirmative. Clinicaltrials.gov has data which implies that this research programme, initially posted on April 22nd 2022, is actively acquiring patients. 40 individuals must be enrolled from a single medical centre."
Who else is applying?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger